Hormone signaling and fatty liver in females: analysis of estrogen receptor α mutant mice.

ABSTRACT:

Background

Treatment with estrogen in early menopausal women protects against development of hepatic steatosis and nonalcoholic fatty liver disease but estrogen has undesirable side effects, which negate its beneficial effects in premenopausal and postmenopausal women. Targeted therapies require better understanding of the target sites and mechanisms by which estrogen signaling exerts its protective effects in women. Estrogen receptor α (ERα) is thought to be the primary mediator for estrogen signaling to protect against hepatic steatosis. ERα has several mechanisms for signal transduction: (1) inducing gene transcription by direct binding to specific DNA sequences, (2) inducing tethered transcription with other DNA-binding factors, and (3) stimulating nongenomic action through mem

SUBMITTER: Hart-Unger S 

PROVIDER: S-EPMC5735425 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature